Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIVOLUMAB vs NORDAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIVOLUMAB vs NORDAZEPAM: Safety Overview

Metric NIVOLUMAB NORDAZEPAM
Total FAERS Reports 87,742 2,790
Deaths Reported 23,086 1,857
Death Rate 26.3% 66.6%
Hospitalizations 36,530 346
Average Patient Age 64.2 yrs 39.7 yrs
% Female Patients 34.0% 28.9%
Manufacturer E.R. Squibb & Sons, L.L.C. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A